Maybank's Abdul Wahid on Risk Management, Capital

May 9 (Bloomberg) -- Abdul Wahid Omar, chief executive officer of Malayan Banking Bhd, known as Maybank, talks about the bank's focus on risk management and compliance with Basel III capital requirements. Maybank was 13th in a survey of the world's strongest banks featured in the June issue of Bloomberg Markets magazine. (Source: Bloomberg)

Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
11:15 - Pfizer and Merck KGaA’s cancer immunotherapy won approval from U.S. regulators for patients with a rare form of skin cancer, and the companies plan to sell the drug for $13,000 a month. Merck KgaA CEO Stegfan Oschmann speaks on "Bloomberg Daybreak Europe." (Source: Bloomberg)
  • Aviva's Diebel Sees No Macro Impact From Healthcare Bill
  • Italy Junior Minister Sees Brexit as EU Opportunity
  • French Presidential Race Takes an Inflammatory Turn